Zinc Shields Damaged Arteries from Rapid Aging

Two Seemingly Unrelated Phenomena Scientists who published their findings in the journal Aging Cell have uncovered that the nuclei in cells lining damaged arteries rapidly deform, triggering accelerated cellular senescence. Supplying these cells with zinc helps to partially reverse this abnormal sha

Two Seemingly Unrelated Phenomena

Scientists who published their findings in the journal Aging Cell have uncovered that the nuclei in cells lining damaged arteries rapidly deform, triggering accelerated cellular senescence. Supplying these cells with zinc helps to partially reverse this abnormal shaping.

The study opens by exploring two distinct ideas that might initially seem disconnected. It first delves into vascular injury, especially during surgical interventions; even the least invasive techniques that cut, scrape, or burn arterial walls inevitably inflict some degree of harm. Examples include catheter placements used to manage heart conditions and the surgical removal of malignant tumors.

The discussion then shifts to the morphology of nuclei inside cells. Irregularly shaped nuclei serve as a hallmark of cellular senescence. Disruptions in the nuclear lamina, the structure that preserves the nucleus's form, are associated with DNA damage. Mutations in the Lamin A gene are famously central to progeria, a condition of premature aging, and the buildup of its immature, ineffective form known as prelamin A has been connected to the aging of blood vessels.

This research effectively connects these two areas, proving that the aging of blood vessels is directly tied to physical trauma.

Abnormal Nuclei in Muscle Cells of Damaged Arteries

The investigators began by analyzing arteries from 18 human subjects. Certain participants had previously undergone percutaneous transluminal angioplasty (PTA), a method that unavoidably harms the femoral arteries, prior to their arteries being excised for separate medical purposes. A comparison group consisted of individuals whose femoral arteries were removed without any prior PTA exposure.

In the arteries from the control group, the nuclei of vascular smooth muscle cells (VSMCs) displayed a smooth, elongated, cigar-like form. In contrast, the VSMC nuclei from the PTA group showed clear dysmorphia, featuring varied shapes and frequent distortions. Researchers replicated this observation in an animal model by using balloons to injure the carotid arteries of rats, resulting in notably deformed VSMC nuclei at the injury sites. These changes in shape emerged right after the trauma occurred.

Such morphological shifts were closely associated with aging processes. Human samples from injured arteries showed higher expression of the senescence marker SA-β-gal. In the rat models, SA-β-gal levels correlated directly with reduced nuclear solidity, confirming that these injuries promote cellular senescence.

The team had earlier identified that platelet-derived microvesicles (pMVs) released post-injury contribute to vascular impairment. In this study, they showed that directly applying pMVs to vascular tissues reproduced the nuclear deformities seen in actual injuries. This effect stemmed from an increase in prelamin A; cells exhibiting greater prelamin A buildup displayed more pronounced dysmorphia.

To further investigate, the researchers employed CRISPR technology to alter cells, preventing proper processing of prelamin A by eliminating the Zmpste24 enzyme. This modification induced identical nuclear abnormalities. Predictably, mice genetically modified to lack this crucial enzyme exhibited hastened vascular aging.

Zinc Emerges as the Critical Factor

Zinc, an essential mineral, plays a vital role in Zmpste24's activity. When zinc was provided together with pMVs, it almost entirely counteracted their harmful impacts. Conversely, TPEN, a compound that binds and removes zinc from cells, triggered nuclear deformities comparable to those from pMVs. Tests on cells lacking Zmpste24 confirmed the enzyme's role in averting these shape changes.

Following vascular injury in VSMCs, levels of ZIP4—a transporter protein that facilitates zinc entry into cells—were reduced. This pattern was mirrored when pMVs were administered directly.

The study progressed to another rat-based trial. Alongside a standard control group, some rats received a diet enriched with zinc, while others were treated with ZIF-8, an innovative nanoparticle that encapsulates zinc within platelet-derived membranes. These animals then experienced induced vascular damage. Rats on the zinc-supplemented diet showed modestly lower prelamin A levels, and those given ZIF-8 displayed even greater reductions, though the injury's consequences were not fully eliminated. Detailed follow-up assessments revealed no adverse reactions from the ZIF-8 treatment in these rats.

The authors conclude that their discoveries highlight a new signaling pathway—the pMVs/ZIP4/zinc/prelamin A axis—that governs nuclear dysmorphia and the aging of blood vessels. Should these results be validated through further studies, incorporating zinc supplements or ZIF-8 nanoparticles into surgical protocols could become a standard measure to safeguard against premature vascular aging.